Cancer Communications

Title Publication Date Language Citations
EDITORIAL ADVISORY BOARD1991/08/01English
INSTRUCTIONS TO CONTRIBUTORS1991/04/01English
INSTRUCTIONS TO AUTHORS1989/01/01English
Note to authors1991/01/01English
ABBREVIATIONS USED IN THIS JOURNAL1991/06/01English
EDITORIAL ADVISORY BOARD1991/09/01English
EDITORIAL ADVISORY BOARD1990/11/01English
ADDITIONS AND CORRECTIONS1989/01/01English
INSTRUCTIONS TO CONTRIBUTORS1991/08/01English
ADDITIONS AND CORRECTIONS1989/11/01English
EDITORIAL ADVISORY BOARD1990/08/01English
ABBREVIATIONS USED IN THIS JOURNAL1990/01/01English
Note to authors1991/06/01English
Note to authors1991/07/01English
EDITORIAL ADVISORY BOARD1990/10/01English
ABBREVIATIONS USED IN THIS JOURNAL1990/01/01English
ABBREVIATIONS USED IN THIS JOURNAL1989/11/01English
ABBREVIATIONS USED IN THIS JOURNAL1991/05/01English
ABBREVIATIONS USED IN THIS JOURNAL1990/08/01English
ABBREVIATIONS USED IN THIS JOURNAL1989/01/01English
EDITORIAL ADVISORY BOARD1991/05/01English
Note to readers1990/12/01English
Addendum to: Vasanthakumar, G.; Ahmed, N. K. Modulation of drug resistance in a daunorubicin resistant subline with oligonucleoside methylphosphate. Cancer Commun. 1: 225–232; 19891990/08/01English
ABBREVIATIONS USED IN THIS JOURNAL1989/01/01English
INSTRUCTIONS TO CONTRIBUTORS1991/03/01English
EDITORIAL ADVISORY BOARD1990/01/01English
EDITORIAL ADVISORY BOARD1991/03/01English
EDITORIAL ADVISORY BOARD1990/01/01English
Note to authors1991/01/01English
Note to readers1990/11/01English